Completed PHASE1 INTERVENTIONAL 1-arm NCT04081376

Generation of Biological Samples Positive to Hydromorphone for Anti-doping Control (HM)

Sponsor: Parc de Salut Mar

Interventions Hydromorphone Hydrochloride

Updated 5 times since 2019 Last updated: Dec 19, 2019 Started: Nov 20, 2019 Primary completion: Dec 18, 2019 Completion: Dec 18, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04081376, this PHASE1 trial focuses on Healthy Volunteers and remains completed. Sponsored by Parc de Salut Mar, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Not Yet Recruiting → Completed
Oct 2019 — Jan 2020 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Parc de Salut Mar

Data source: Parc de Salut Mar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain